Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

MR antagonists may improve skin health and wound healing, especially in aging.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

New compounds may help treat heart disease by activating specific potassium channels.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.